
The Public Chafed the Last Time the GOP Tried to Cut Medicaid
Will This Time be Different? Past Health Bills Hold Clues
Health Care Access & Coverage | Population Health
Blog Post
Firearm violence is a public health crisis that continues to worsen in the United States. This crisis has escalated significantly with the arrival of the COVID-19 pandemic, further stressing our communities. Patients injured by firearms require rapid transport to trauma centers for life-saving procedures. For these critically injured patients, truly every minute counts. In a new JAMA Surgery study, LDI Senior Fellows Elinore Kaufman and Jeremy Cannon, along with their colleagues, found that longer predicted transport time to a trauma center is associated with higher rates of death.
If time is so important, what might local policymakers do to reduce the time to care? Philadelphia utilizes a practice known as “scoop and run.” In a previous study, Dr. Cannon found that if police officers were the first to arrive at a firearm injury scene, the most severe injuries were more likely to be alive on arrival to the hospital when transported by police. What this study points out is that time is a critical factor, and systems need to focus on reducing the time to care as much as possible to reduce deaths from gun violence in U.S. cities.
The study, “Association Between Geospatial Access to Care and Firearm Injury Mortality in Philadelphia,” was published on August 24, 2022, in JAMA Surgery. Authors include James P. Byrne, Elinore Kaufman, Dane Scantling, Vicky Tam, Niels Martin, Shariq Raza, Jeremy Cannon, C. William Schwab, Patrick M. Reilly, and Mark J. Seamon.
Will This Time be Different? Past Health Bills Hold Clues
The Inflation-Adjusted NIH Budget is Lower in 2024 Than It Was at Its 2003 Peak
Supplement to Response to Request for Technical Assistance
But Many Other Factors Played a Role in Denying Loans, LDI Fellow Says
A Simple Change to Clinicians’ Prescribing System Reduced Prescription Disparities by Race, Ethnicity, Insurance Type, and Income
Offit and Buttenheim Criticize HHS Placebo Trial Mandate as Unethical, Misleading, and a Threat to Vaccine Confidence